Cardiac Assessment with PET [0.03%]
心肌PET显像评估
Amol Takalkar,Anshul Agarwal,Scott Adams et al.
Amol Takalkar et al.
Positron emission tomography (PET) has been very well validated for assessing myocardial viability, and emerging sophisticated hybrid imaging technologies involving PET with other imaging modalities offer tremendous promise for delivering a...
A Multimodality Imaging Review of Malignant Pleural Mesothelioma Response Assessment [0.03%]
恶性胸膜间皮瘤多模式影像学评价进展
Anna K Nowak,Roslyn J Francis,Sharyn I Katz et al.
Anna K Nowak et al.
Assessment of response is important to interpret early phase clinical trial results and to guide individual patient management. In malignant pleural mesothelioma (MPM), the circumferential growth pattern of the disease, the presence of pleu...
Multimodality Imaging Review of Malignant Pleural Mesothelioma Diagnosis and Staging [0.03%]
恶性胸膜间皮瘤诊断与分期的多模态影像评估
Victor H Gerbaudo,Sharyn I Katz,Anna K Nowak et al.
Victor H Gerbaudo et al.
Early diagnosis and accurate disease staging in patients with malignant pleural mesothelioma (MPM) are essential in classifying such patients into prognostic subgroups to allow delivery of stage-specific therapies. This review addresses the...
The Role of PET in the Evaluation, Treatment, and Ongoing Management of Lung Cancer [0.03%]
PET在肺癌评估、治疗及长期管理中的作用
Kevin Stephans,Anton Khouri,Mitchell Machtay
Kevin Stephans
PET has gained a major role in the evaluation and treatment of lung cancer over the past two decades. Over that time span PET and treatment techniques have both evolved substantially. While technical changes in PET and PET/computed tomograp...
Sanjay Thulkar,Gauthier Namur,Roland Hustinx et al.
Sanjay Thulkar et al.
Computed tomography (CT) is the primary noninvasive imaging modality for staging of non-small cell lung cancer. Magnetic resonance imaging compliments CT in tumor staging in specific situations. [(18)F]Fluorodeoxyglucose positron emission t...
Mohamed Houseni,Wichana Chamroonrat,Hongming Zhuang et al.
Mohamed Houseni et al.
A common clinical dilemma is the evaluation of pulmonary nodules detected on imaging. Differentiation between malignant and benign pulmonary nodules is a complex problem despite major advances in medical imaging. Accurate diagnosis helps to...
Drew A Torigian,Abass Alavi
Drew A Torigian
Evaluation of Musculoskeletal Disorders with PET, PET/CT, and PET/MR Imaging [0.03%]
PET、PET/CT和PET/MRI在肌肉骨骼系统疾病评估中的应用
Karen Chen,Judy Blebea,Jean-Denis Laredo et al.
Karen Chen et al.
18F-2-fluoro-2-deoxy-D-glucose-PET has an established role in the evaluation of hip periprosthetic infection and musculoskeletal malignancies. Determination of its role in the management of inflammatory arthritis and diabetic foot complicat...
Complementary Assessment of Abdominopelvic Disorders with PET/CT and MRI [0.03%]
PET/CT和MRI在 abdominopelvic疾病中的互补应用评估研究
Roland Hustinx,Drew A Torigian,Gauthier Namur
Roland Hustinx
This article reviews the current performance and status of PET/CT and MR imaging in four different abdominopelvic malignancies: cervical, pancreatic, and rectal cancers and liver metastases, as well as in Crohn's disease. The authors discus...
Amol Takalkar,Wengen Chen,Benoit Desjardins et al.
Amol Takalkar et al.
PET provides high-resolution images of radiopharmaceutical biodistribution in vivo. Fluorine-18-labeled fluorodeoxyglucose (FDG)-PET is an established entity in the work-up of several oncologic disorders and is making forays in the diagnosi...